Patent Assignment
Reel/Frame 050056/0731
Assignment of Assignor's Interest
Recorded: 2019-08-14
Pages: 46
Assignor
CEMPRA PHARMACEUTICALS, INC.
Executed: 2019-05-08
Assignee
TETARD, INC.
8129 MCQUAID ROAD, WOOSTER, OHIO, 44691
Covered Properties
(39)
Copper-Catalysed Ligation of Azides and Acetylenes
Novel Antibacterial Agents
Copper-Catalysed Ligation of Azides and Acetylenes
Novel Antibacterial Agents
Process for the Preparation of Macrolide Antibacterial Agents
Copper-Catalysed Ligation of Azides and Acetylenes
Biodefenses Using Triazole-Containing Macrolides
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Novel Antibacterial Agents
Methods for Treating Malaria, Tuberculosis and Mac Diseases
Copper-Catalysed Ligation of Azides and Acetylenes
Compounds and Methods for Treating Inflammatory Diseases
Patent:
9,937,194 →
Application:
13/596,875 →
Crystalline Forms of a Macrolide, and Uses Therefor
Process for Preparing Triazole-Containing Ketolide Antibiotics
Novel Antibacterial Agents
Hydrogen Bond Forming Fluoro Ketolides for Treating Diseases
Crystalline Forms of a Macrolide, and Uses Therefor
Copper-Catalysed Ligation of Azides and Acetylenes
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Parenteral Formulations for Administering Macrolide Antibiotics
Copper-Catalysed Ligation of Azides and Acetylenes
Copper-Catalysed Ligation of Azides and Acetylenes
Biodefenses Using Triazole-Containing Macrolides
Methods for Treating Respiratory Diseases and Formulations Therefor
Convergent Processes for Preparing Macrolide Antibacterial Agents
Process for the Preparation of Macrolide Antibacterial Agents
Processes for Preparing Fluoroketolides
Application:
15/555,701 →
Publication:
US 2018/0044365
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Application:
15/875,187 →
Publication:
US 2018/0369262
Convergent Processes for Preparing Macrolide Antibacterial Agents
Application:
15/899,844 →
Publication:
US 2019/0023731
Crystalline Forms of a Macrolide, and Uses Therefor
Application:
15/904,826 →
Publication:
US 2019/0040096
Compounds and Methods for Treating Inflammatory Diseases
Application:
15/904,882 →
Publication:
US 2019/0038653
Processes for Preparing Macrolides and Ketolides and Intermediates Therefor
Application:
15/913,650 →
Publication:
US 2019/0048035
Parenteral Formulations of Macrolide Antibiotics
Application:
15/918,098 →
Publication:
US 2019/0054059
Novel Antibacterial Agents
Application:
15/934,430 →
Publication:
US 2019/0062342
Powder Oral Suspension Formulations of Antibacterial Agents
Application:
16/130,217 →
Publication:
US 2019/0209530
Process for the Preparation of Macrolide Antibacterial Agents
Application:
16/155,939 →
Publication:
US 2019/0241602
Parenteral Formulations for Administering Macrolide Antibiotics
Application:
16/205,445 →
Publication:
US 2019/0328759
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Mar 15, 2011
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025958/0519 →
Confirmatory License
Apr 11, 2014
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032670/0615 →
Confirmatory License
Apr 11, 2014
From: THE SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032670/0562 →
Change of Name
Aug 12, 2015
From: OPTIMER PHARMACEUTICALS, INC.
To: OPTIMER PHARMACEUTICALS LLC
Reel/Frame 036333/0793 →
Nunc Pro Tunc Assignment
Aug 14, 2015
From: OPTIMER PHARMACEUTICALS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 036328/0122 →
Confirmatory License
Dec 15, 2015
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037292/0503 →
Security Interest
Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Security Interest
Jul 25, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 046454/0392 →
Release of Security Interest
Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →